
Evaluation of high-dose atorvastatin pretreatment influence in patients preconditioning of post coronary artery bypass graft surgery: A prospective triple blind randomized clinical trial
Author(s) -
Misagh Bastani,
Mohammad Bagher Khosravi,
Masih Shafa,
Simin Azemati,
Behzad Maghsoodi,
Elham Asadpour
Publication year - 2021
Publication title -
annals of cardiac anaesthesia/annals of cardiac anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.42
H-Index - 27
eISSN - 0974-5181
pISSN - 0971-9784
DOI - 10.4103/aca.aca_34_19
Subject(s) - medicine , atorvastatin , randomized controlled trial , coronary artery bypass surgery , clinical trial , artery , cardiology , prospective cohort study , surgery , anesthesia
Atorvastatin is considered as lipid reductive drugs with anti-inflammatory and pleotherapic effects in coronary artery bypass graph (CABG).